Work

Protection from malaria infection using liver-targeted siRNA

Year: 2025

Type: article

Abstract: infection using human liver-chimeric mice. The data suggest siRNA as a promising host-based approach to prevent malaria infection.

Source: Molecular Therapy — Methods & Clinical Development

DOI: 10.1016/j.omtm.2025.101516

Authors: R.W.J. Steel, A. Schepis, T. Nguyen, S. Milstein, K. Yucius, H.C. Tu, E. Fishilevich, P. Haslett, S.H.I. Kappe

Institutions: Seattle Children's Research Institute, Alnylam Pharmaceuticals (United States), University of Washington

Language: English

Topic: Malaria Research and Control

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,900

Funder: Alnylam Pharmaceuticals

OpenAlex ID: W4411399290

FWCI:

Cites: 38

Cited by:

Related to: 10